INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on June 6, 2022 in Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. Pharmaceutical Investing
SHAREHOLDER ALERT: AUPH IRNT BKKT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Aurinia Pharmaceuticals Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GRAB, IBM and AUPH Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ERIC, ABBV and SDIG Pharmaceutical Investing
Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes Pharmaceutical Investing
Health Canada Approves VRAYLAR® for the Treatment of Bipolar l Disorder and Schizophrenia in Adults Pharmaceutical Investing
Pfizer and Biohaven's VYDURA® Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine Life Science Investing
AUPH Stock News: Robbins LLP Investigates Aurinia Pharmaceuticals Inc. on Behalf of Shareholders Pharmaceutical Investing
SHAREHOLDER ALERT: ABBV SDIG LICY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Securities Fraud Class Action Lawsuit Pharmaceutical Investing
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ERIC, RIVN and ABBV Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
